Optimizing care for atopic dermatitis patients during the COVID-19 pandemic - 23/07/20
Funding sources: None. |
|
Conflicts of interest: Dr Alavi has consulted for AbbVie, Janssen, Leo, Galderma, Novartis, Infla Rx, and Valeant, and is an investigator for AbbVie, Novartis, Regeneron, Pfizer, Boehringer Ingelheim, Glenmark, Merck Serono, Roche, Xoma, Infla Rx, UCB, and Xenon. Dr Alavi has also received a grant from AbbVie. Dr Shi is a stock shareholder of Learn Health and has served as a consultant or investigator for or has received research funding from Sanofi/Regeneron, Eli Lilly, Dermira, Novartis, AbbVie, Sun Pharma, Pfizer, Leo, Menlo Therapeutics, Burt's Bees, GpSkin, and Skin Actives Scientific. Dr Hsiao, Ms Shah, and Ms Sachdeva have no conflicts of interest to declare. |
|
Reprints not available from the authors. |
Vol 83 - N° 2
P. e165-e167 - août 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.